Home Page Overall Ranking ROE Ranking P/E Ranking Dividend Yield Capitalization Our eBook Our Book Contact










Isin US00287Y1091
Ticker ABBV
Company ABBVIE
Currency $
Price
Aware Investor Index (AII) 92.1729
Recommendation STRONG BUY
P/E 80.50
ROE 100.00 %
Capitalization 328,316,720,000 $
Dividend Yield 1.05 %
P/S 14.36
AII Position 41
P/E Position 707
ROE Position 29
Capitalization Position 11
Dividend Yield Position 510
Sales 22,859,000,000 $
10-Year Average Earnings 4,078,250,000 $
Shares Outstanding 1,637,000,000
Equity 3,945,000,000 $
Dividend per Share 2.1 $
Industry Pharmaceutical
Country United States
ABBVIE Investor Relations Web Site http://www.abbvieinvestor.com







Sales:

YEAR MONTH AMOUNT
2015 12 22,859,000,000.00 $
2014 12 19,960,000,000.00 $
2013 12 18,790,000,000.00 $
2012 12 18,380,000,000.00 $
2011 12 17,444,000,000.00 $
2010 12 15,638,000,000.00 $
2009 12 14,214,000,000.00 $
2008 12 14,179,000,000.00 $

Earnings:

YEAR MONTH AMOUNT
2015 12 5,144,000,000.00 $
2014 12 1,774,000,000.00 $
2013 12 4,128,000,000.00 $
2012 12 5,275,000,000.00 $
2011 12 3,433,000,000.00 $
2010 12 4,178,000,000.00 $
2009 12 4,636,000,000.00 $
2008 12 4,058,000,000.00 $

Equity:

YEAR MONTH AMOUNT
2015 12 3,945,000,000.00 $
2014 12 1,742,000,000.00 $
2013 12 4,492,000,000.00 $
2012 12 3,363,000,000.00 $

Shares Outstanding:

YEAR MONTH AMOUNT
2015 12 1,637,000,000
2014 12 1,610,000,000
2013 12 1,604,000,000
2012 12 1,577,000,000

 












Bloomberg News for ABBVIE:

Jun 12, 2013
EPS in the First Quarter of ’13 for S&P 500 Stocks by Sectors
4.8 Mar 4/23 AMGN Amgen Inc 1.96 1.61 21.7 1.84 6.5 Mar 4/26 ABBV AbbVie Inc. 0.68 0.56 21.4 0.67 1.5 Mar 5/2 ACT Actavis Inc ...
Jun 12, 2013
EPS in the First Quarter of ’13 for S&P 500 Stocks by Industry
8.6 Mar 4/23 AMGN Amgen Inc 1.96 1.61 21.7 1.84 6.5 Mar 4/26 ABBV AbbVie Inc. 0.68 0.56 21.4 0.67 1.5 Mar 5/2 ACT Actavis Inc ...
Jun 12, 2013
Positive EPS Surprises for First Quarter of ’13 for S&P 500
62 1.6 Mar 4/30 EQR Equity Residential 0.64 0.61 4.9 0.63 1.6 Mar 4/26 ABBV AbbVie Inc. 0.68 0.56 21.4 0.67 1.5 Mar 4/25 CELG Celgene Corp ...
Mar 21, 2017
Goldman Says These Dividend Stocks Will Do Well Even With the Fed Hiking Rates
WHR, HD, LOW, PHM, MO, RAI, ADM, CVS, MJN, VLO, PSX, MPC, TSO, LM, HBAN, KEY, MMC, MS, BEN, UNM, ABBV, PFE, AMGN, CAH, MDT, ABT, DGX, BA, NLSN, ITW, HON, IR, CSCO, XRX, HPQ, IBM, TXN, MSI, MSFT, GLW...
May 16, 2013
And the Winner of the Top Student-Run Investment Fund Is ...
Apache (APA), -15.42 percent UnitedHealth Group (UNH), -2.52 percent AbbVie (ABBV), -2.39 percent FIXED INCOME First Place: Stetson University...
Nov 14, 2014
Maverick Capital Ltd Holdings in 3rd Quarter: 13F Alert
Plc-Series C LBTYK US 279,296,113 6,809,609 238,560 AbbVie Inc ABBV US 272,833,865 4,723,578 1,488,445 CBS Corp-Class B Non Voting CBS US 258,296...
Dec 10, 2012
Abbott Spinoff AbbVie Begins Trading to Determine Value
percent to $30.30 at 4 p.m. New York time. AbbVie when-issued shares, trading under the ticker ABBV-W, opened at $37 and fell 5.4 percent to $35. The secondary market for the when-issued shares...
Feb 14, 2013
SAC Capital Advisors Holdings in 4th Quarter: 13F Alert
Alcatel-Lucent-Sponsored ADR ALU US 54,244,194 39,024,600 39,024,600 AbbVie Inc ABBV US 51,877,221 1,518,654 1,518,654 Analog Devices Inc ADI US 47,426...
May 3, 2013
S&P 500 Stocks Biggest Weekly Changes in Target Price
44.58 42.09 3.526 THC TENET HEALTHCAR 5.90 14 49.18 46.44 4.043 ABBV ABBVIE INC 5.85 6 46.22 43.67 3.800 TWX TIME WARNER INC 5...
Jun 12, 2013
Higher, Lower, Unchanged and Reversed EPS for S&P 500
6.7 Mar 4/23 AMGN Amgen Inc 1.96 1.61 21.7 1.84 6.5 Mar 4/26 ABBV AbbVie Inc. 0.68 0.56 21.4 0.67 1.5 Mar 4/18 AN AutoNation Inc ...


Google News for ABBVIE:

Investorplace.com (blog) - 1 day ago
AbbVie (ABBV) a Buy on Healthy Earnings Momentum
AbbVie Inc (NYSE:ABBV) is ranked as a Buy using the approach to investing of Louis Navellier and his Portfolio Grader stock evaluator.
Nasdaq - 6 days ago
AbbVie Inc. (ABBV) Ex-Dividend Date Scheduled for October 12, 2017
AbbVie Inc. ( ABBV ) will begin trading ex-dividend on October 12, 2017. A cash dividend payment of $0.64 per share is scheduled to be paid ...
StreetInsider.com
AbbVie (ABBV) Stock Up Almost 17% in One Month: Here's Why
AbbVie Inc. ABBV shares have gained an impressive 16.7% in the past month, comparing favorably with a gain of 4.5% recorded by the ...
Simply Wall St
Is the Options Market Predicting a Spike in AbbVie (ABBV) Stock?
Investors in AbbVie Inc. ABBV need to pay close attention to the stock based on moves in the options market lately. That is because the Oct 13, ...
StockNewsJournal
How Does AbbVie Inc. (ABBV) Stack Up Right Now?
AbbVie Inc. (ABBV) is an interesting player in the Healthcare space, with a focus on Drug Manufacturers – Major. The stock has been active on ...
Nasdaq - 5 Oct 2017
UBS Downgrades AbbVie; Here's What Changed Analysts' View
UBS downgraded shares of AbbVie Inc (NYSE: ABBV), citing valuation and a likely delay in the U.S. biosimilar competition for Humira. Humira ...
StockNewsJournal
Best Healthcare Stocks: AbbVie
Among the companies currently selected by the system, AbbVie looks like a ... AbbVie (ABBV) is a drug manufacturing company with a big ...
Economic News
Plenty Of Opportunity In AbbVie, Even After Recent Run
Analysts at Leerink Swann turned bullish on AbbVie Inc (NYSE: ABBV) and sees continued upside to the stock on top of the 43 percent gain ...
NY Stock News
Hold Recommendation for AbbVie (ABBV) Stock Kept
Currently, AbbVie Inc (NYSE:ABBV) has a Hold using the Portfolio Grader stock evaluator of Louis Navellier, which incorporates his investing ...
Nasdaq - 5 days ago
Choosing Between Merck & Co., Inc. (MRK) and AbbVie Inc. (ABBV)
AbbVie Inc. (NYSE:ABBV), on the other hand, is up 45.38% year to date as of 10/16/2017. It currently trades at $91.04 and has returned 0.29% ...


Back